New leukemia treatment begins first human testing
NCT ID NCT06514768
Summary
This early study is testing a new treatment called JY231 injection for adults and children with B-cell acute lymphoblastic leukemia (B-ALL). Researchers will give the injection to 20 participants to check if it's safe and what side effects might occur. They'll also look for early signs that it might help control the leukemia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
920th HJointLogistics
RECRUITINGKunming, Yunnan, China
Conditions
Explore the condition pages connected to this study.